Skip to content
My WebMD Sign In, Sign Up

Psoriasis Health Center

Font Size

New Skin Cream Approved for Psoriasis

Taclonex Combines 2 Psoriasis Drug Treatments

WebMD Health News
Reviewed by Louise Chang, MD

Jan. 13, 2006 -- The FDA has approved the first skin cream to combine two popular psoriasis therapies in a single, once-a-day treatment.

More than 4.5 million people suffer from psoriasis, which is a chronic skin disease that can cause patches of itchy, scaly, and inflamed skin. It is not a contagious disease. Although there isn't a cure for the disease, several treatments can keep it under control.

Taclonex combines two widely used psoriasis treatments: a corticosteroid to treat inflammation and a form of vitamin D to control cell growth.

The FDA based its approval on studies that showed the skin cream significantly improved mild to severe cases of psoriasis.

Taclonex was developed in Denmark in 2001 and has been used in 63 countries under the names Dovobet and Daivobet.

Warner Chilcott will market Taclonex in the U.S. and expects to have the drug available in pharmacies by June 2006, the company says in a news release.

Today on WebMD

Woman scratching shoulder
Health Check
Contact Dermatitis
Video
 
Psoriasis Triggers Slideshow
Slideshows
!!69x75_psoriasis_1.jpg
Video
 
Top Psoriasis Treatments To Try At Home
Article
Woman sitting in front of UV lights
Slideshow
 
Beware Miracle Diets For Psoriasis
Article
Psoriasis Laser Therapy
Video
 
10 Questions About Psoriasis To Ask Your Doctor
Article
psoriasis on elbow
Article
 
Psoriasis (Moderate to Severe)
Article
Psoriatic Arthritis Do You Know The Symptoms
Article